Khoso Baluch
CIK 1686223 · View on SEC EDGAR ↗
First SEC filing: June 12, 2023 · Latest: June 12, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | PCSA | P | 2,269 | $2.54 | $5,763 | 2,325 Direct | +4051.79% | Acquired | -13.4% (price as of 2026-08-21) |
| Aug. 11, 2025 | LGVN | P | 29,415 | — | — | 29,415 Direct | — | Acquired | (price as of 2026-08-21) |
| Aug. 11, 2025 | LGVN | P | 11,766 | — | — | 52,516 Direct | +28.87% | Acquired | (price as of 2026-08-21) |
| Dec. 2, 2024 | LGVN | S | 1,250 | $2.07 | $2,588 | 23,750 Direct | -5.00% | Disposed | -58.9% (price as of 2026-08-21) |
| Dec. 29, 2023 | LGVN | P | 8,322 | $1.43 | $11,900 | 15,000 Direct | +124.62% | Acquired | -94.1% (price as of 2026-08-21) |
| Dec. 28, 2023 | LGVN | P | 1,678 | $1.40 | $2,349 | 6,678 Direct | +33.56% | Acquired | -93.9% (price as of 2026-08-21) |
| Aug. 13, 2020 | CRMD | P | 4,830 | $4.14 | $19,996 | 60,905 Direct | +8.61% | Acquired | 99.5% (price as of 2026-08-21) |
| March 18, 2020 | CRMD | P | 3,500 | $2.61 | $9,135 | 56,075 Direct | +6.66% | Acquired | 216.5% (price as of 2026-08-21) |
| May 17, 2017 | CRMD | P | 75,000 | $0.48 | $36,000 | 85,000 Direct | +750.00% | Acquired | 244.2% (price as of 2026-08-21) |
| Dec. 9, 2016 | CRMD | P | 10,000 | $1.77 | $17,700 | 10,000 Direct | — | Acquired | -6.7% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 26, 2026 | PCSA | Restricted Stock Units | Common Stock (33,500) | $0.00 | — | 33,500 | Acquired |
| June 26, 2026 | PCSA | Restricted Stock | Common Stock (203) | $0.00 | — | 203 | Disposed |
| Oct. 1, 2025 | PCSA | Stock Options (Right to Buy) | Common Stock (300,000) | $0.20 | — | 300,000 | Acquired |
| Oct. 1, 2025 | PCSA | Restricted Stock Units | Common Stock (100,000) | $0.00 | — | 100,000 | Acquired |
| Aug. 11, 2025 | LGVN | Warrant (right to buy) | Class A Common Stock (29,415) | $0.85 | Aug. 11, 2027 | 29,415 | Acquired |
| July 24, 2025 | PCSA | Restricted Stock | Common Stock (175,299) | $0.00 | — | 175,299 | Acquired |
| Sept. 3, 2024 | PCSA | Restricted Stock | Common Stock (31,206) | $0.00 | — | 31,206 | Acquired |
| Sept. 3, 2024 | PCSA | Restricted Stock | Common Stock (31,206) | $0.00 | — | 31,206 | Acquired |
| Dec. 21, 2023 | LGVN | Stock Option (Right to buy) | Common Stock (12,000) | $1.25 | Dec. 21, 2033 | 12,000 | Acquired |
| June 27, 2023 | PCSA | Restricted Stock | Common Stock (101,365) | $0.00 | — | 101,365 | Acquired |
| June 27, 2023 | PCSA | Restricted Stock | Common Stock (15,455) | $0.00 | — | 15,455 | Disposed |
| Jan. 11, 2021 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (320,000) | $8.32 | Jan. 11, 2031 | 320,000 | Acquired |
| Feb. 25, 2020 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (100,630) | $5.63 | Feb. 25, 2030 | 100,630 | Acquired |
| Sept. 26, 2019 | CRMD | Stock Option (Right to Buy Common Stock) | Common Stock (120,000) | $6.82 | Sept. 26, 2029 | 120,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (1,250,000) | $2.52 | Sept. 30, 2026 | 1,250,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (300,000) | $2.52 | Sept. 30, 2026 | 300,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (300,000) | $2.52 | Sept. 30, 2026 | 300,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (1,250,000) | $2.52 | Oct. 3, 2026 | 1,250,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (300,000) | $2.52 | Oct. 3, 2026 | 300,000 | Acquired |
| Oct. 3, 2016 | CRMD | Stock Option (right to buy) | Common Stock (300,000) | $2.52 | Oct. 3, 2026 | 300,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $366,700 | — | — | $1,698,080 | — | — | $531,393 | $2,596,173 |
| 2020 | $425,000 | — | — | $428,583 | $340,000 | — | $40,088 | $1,233,671 |
| 2019 | $387,885 | — | — | $1,133,600 | $248,000 | — | $26,344 | $1,795,829 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.